Alex Moy: Taking Steps to Raise for Research Story September 22, 2026 When people think about fundraising, they often wonder: Can one person really make a difference? Alex Moy's story answers...
Community Spotlight: How Nishant Rastogi is Investing in a Brighter Future Story September 22, 2026 Turning a promising discovery into a new diagnostic tool or treatment that can change someone’s life takes more than...
What should I say if my kids worry about getting lupus? Story August 27, 2026 How to talk to your child about their risk of lupus Many people living with lupus worry about how...
A New Frontier in Lupus Treatment: One Researcher’s Hope for Children Story August 27, 2026 Engineered cell therapies have been generating significant excitement as researchers explore whether advances that have transformed some cancer treatments...
How can I host my own fundraiser? Story August 27, 2026 Hosting your own fundraising event can make a tremendous difference to accelerate scientific discovery and transforming lives. And, you...
Lupus and Allied Diseases Association Donates $200,000 to Accelerate Lupus Research Progress at 2026 Lupus Charity Golf Classic News Update August 24, 2026 The Lupus Research Alliance shares its heartfelt appreciation with the Lupus and Allied Diseases Association, Inc. (LADA) for its generous $200,000...
Lupus Research Alliance Welcomes U.S. FDA Breakthrough Therapy Designation for Enpatoran for the Treatment of Lupus with Skin Manifestations Press Release July 9, 2026 The Lupus Research Alliance welcomes the decision by the U.S. Food and Drug Administration (FDA) to grant Breakthrough Therapy...
NFL Champion Willie Colon Rallies Support for Lupus Research at Annual Golf Fundraiser Press Release June 23, 2026 The Lupus Research Alliance (LRA), the world's largest private funder of lupus research, teamed up with Willie Colon, retired...
Emmitt Henderson III: Finding Strength in Building Community Story June 22, 2026 While 90% of people with lupus are women, the 10% of men also impacted by lupus face the same...
Late-Breaking Data at EULAR Shows Investigational Drug Nipocalimab Significantly Reduces Disease Activity in Lupus News Update June 3, 2026 The Lupus Research Alliance is encouraged by positive late-breaking Phase 2 data with nipocalimab, an investigational drug in development...
Positive Results of Phase 3 Dapirolizumab Pegol Trial in Systemic Lupus Erythematosus Shown in Published Paper News Update June 1, 2026 The Lupus Research Alliance welcomes additional positive results from the Phase 3 PHOENYCS GO study showing that combined with...
Lupus Research Alliance and Genentech Fund Researchers Translating CAR T Success into Durable Lupus Treatments Press Release May 26, 2026 Collaborative research explores how breakthrough engineered therapy works, why remission lasts for some patients, and how to extend its benefits...